drugset / Trial / NCT02799368

Summary

As iodinate contrast media (CM) has been widely used in current medical practice, contrast induced acute kidney injury (CI-AKI) has been an important issue. Previously, many guidelines suggested prophylaxis protocol using 0.9% saline when CM is administrated to high risk patients. However, recent studies showed that 0.9% saline might induce metabolic acidosis due to its supra-physiologic chloride component, and therefore renal vasoconstriction. In spite of protective effect by volume expansion with saline infusion, this renal vasoconstriction might have conflicting effect on renal function, as hypoxic injury is suspected to be the main cause of CI-AKI. In contrast to 0.9% saline, balanced salt solution has physiologic level of chloride and neutral pH. Also, recent studies proved preventive effect of balanced salt solution for AKI in several clinical settings. Hence, the investigators planned a prospective randomized controlled trial comparing 0.9% saline and balanced salt solution to prevent CI-AKI.

Timeline

Start
2016-11
Primary completion
2019-05
Completion
2020-03

Outcome

Missed primary endpoint

paper The occurrence of CI-AKI in the study (10 [4.2%]) and control (17 [6.8%]) groups was not significantly different (P = 0.27). PMID 32734238 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator CJ 0.9% Normal Saline Injection Unknown 1.5 unknown Intravenous
Subject CJ Plasma Solution A Injection Unknown 1.5 unknown Intravenous